[Malignant neuroleptic syndrome and serotoninergic syndrome: two cases].
M J
MJ
Bruscas Alijarde
L
L
de Benito Cordón
D
D
García Mateos
M
M
Ruiz Clemente
M J
MJ
Hervás Laguna
D000328:Adult; D003024:Clozapine / Q000009:adverse effects; D003511:Cyclohexanols / Q000009:adverse effects; D005473:Fluoxetine / Q000009:adverse effects; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D012702:Serotonin Antagonists / Q000009:adverse effects; D020230:Serotonin Syndrome / Q000175:diagnosis*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D000069470:Venlafaxine Hydrochloride
D003024:Clozapine; D003511:Cyclohexanols; D005473:Fluoxetine; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride